Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Lawyers who scored verdicts of $140 million and $150 million last year in the first trials over low testosterone medications have switched lead counsel for a trial that begins on Monday.

The trial, which is expected to last two weeks, comes in a case brought by Robert Nolte, an Arizona man who took AndroGel, a prescription gel used to treat low testosterone. It’s the third trial against AbbVie Inc. and Abbott Laboratories Inc., which are among several defendants named in 6,000 lawsuits coordinated in multidistrict litigation in federal court in Chicago. But unlike the prior AbbVie trials, which alleged the drugs caused heart attacks, this month’s trial makes claims over blood clots. Also, instead of Seeger Weiss, the lead trial counsel for the plaintiffs was set to be Ronald Johnson of Schachter, Hendy & Johnson in Fort Wright, Kentucky. Joining him on the trial team are Morgan & Morgan’s Frank Petosa of Fort Lauderdale and Keith Mitnik of Orlando, and Douglas & London’s Stephanie O’Connor in New York.

“It is a different trial team this go-round from the plaintiffs’ side,” said Trent Miracle, co-lead counsel in the multidistrict litigation over low testosterone drugs along with Johnson and Chris Seeger of New York’s Seeger Weiss.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Amanda Bronstad

Amanda Bronstad is the ALM staff reporter covering class actions and mass torts nationwide. She writes the email dispatch Critical Mass. She is based in Los Angeles.

More from this author

Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

On Trial: Lessons from a lifetime in the courtroomBook

Written by a distinguished N.Y. trial attorney, it distills the author's forty years of courtroom experience into a highly readable trove of wisdom and common-sense advic...

Get More Information

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.